[HTML][HTML] GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
T Gargett, LM Ebert, NTH Truong, PM Kollis… - … for Immunotherapy of …, 2022 - europepmc.org
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong, PM Kollis… - 2022 - digital.library.adelaide.edu.au
Background: Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
[PDF][PDF] GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and 1 clinically feasible therapy for glioblastoma 2
T Gargett - scholar.archive.org
All donors provided informed consent for the use of their de-identified tissue and blood 38
samples in this study. Use of human glioblastoma patient samples was approved by the 39 …
samples in this study. Use of human glioblastoma patient samples was approved by the 39 …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong… - Journal for …, 2022 - search.proquest.com
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong, PM Kollis… - bioRxiv, 2022 - biorxiv.org
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
[HTML][HTML] GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong, PM Kollis… - … for ImmunoTherapy of …, 2022 - jitc.bmj.com
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong… - Journal for …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma
T Gargett, LM Ebert, NTH Truong… - Journal for …, 2022 - researchnow.flinders.edu.au
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma.
T Gargett, LM Ebert, NTH Truong, PM Kollis… - … for Immunotherapy of …, 2022 - europepmc.org
Background Aggressive primary brain tumors such as glioblastoma are uniquely
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …
challenging to treat. The intracranial location poses barriers to therapy, and the potential for …